AVUV vs IBB
Avantis US Small Cap Value ETF vs iShares Biotechnology ETF
- • AVUV has the lower expense ratio at 0.25% vs 0.44% for IBB.
- • AVUV pays a higher dividend yield (1.29%).
Side-by-side metrics
| Metric | AVUV | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.25% | 0.44% |
Dividend yield Trailing 12-month yield. | 1.29% | 0.23% |
AUM Assets under management — bigger funds are typically more liquid. | $26.16B | $7.95B |
YTD return | 18.36% | 3.10% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.10 | 0.74 |
P/E ratio | 13.44 | 23.72 |
Last price | $119.18 | $170.10 |
Inception | — | — |
Issuer | Avantis | iShares |
AVUV top holdings
| VSAT | Viasat Inc | 1.09% |
| SM | SM Energy Co | 0.94% |
| MATX | Matson Inc | 0.92% |
| AVT | Avnet Inc | 0.88% |
| FIVE | Five Below Inc | 0.81% |
| GATX | GATX Corp | 0.80% |
| LEA | Lear Corp | 0.79% |
| SNEX | StoneX Group Inc | 0.76% |
| AROC | Archrock Inc | 0.75% |
| PLXS | Plexus Corp | 0.75% |
IBB top holdings
| AMGN | Amgen Inc | 7.37% |
| GILD | Gilead Sciences Inc | 7.32% |
| VRTX | Vertex Pharmaceuticals Inc | 7.21% |
| REGN | Regeneron Pharmaceuticals Inc | 6.55% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.71% |
| ARGX | argenx SE ADR | 3.33% |
| INSM | Insmed Inc | 2.70% |
| BIIB | Biogen Inc | 2.67% |
| NTRA | Natera Inc | 2.40% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.27% |
About AVUV
AVUV (Avantis US Small Cap Value ETF) is US small-cap value with profitability screen. Managed by Avantis, the fund carries $26.2B in assets under management, an expense ratio of 0.25%, a dividend yield of 1.29%. Its largest holding is Viasat Inc (VSAT), which represents 1.1% of the portfolio. Real Estate is the fund's largest sector exposure at 0.7%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $7.9B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.23%. Its largest holding is Amgen Inc (AMGN), which represents 7.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.